APA (7th ed.) Citation

D, R., V, J., V, Z., J, J. U., N, J., M, M., . . . J, J. J. (2024). Multiple Benefits of Empagliflozin in PCOS: Evidence from a Preclinical Rat Model. Pathophysiology : the official journal of the International Society for Pathophysiology, 31(4), 559. https://doi.org/10.3390/pathophysiology31040041

Chicago Style (17th ed.) Citation

D, Rakic, et al. "Multiple Benefits of Empagliflozin in PCOS: Evidence from a Preclinical Rat Model." Pathophysiology : The Official Journal of the International Society for Pathophysiology 31, no. 4 (2024): 559. https://doi.org/10.3390/pathophysiology31040041.

MLA (9th ed.) Citation

D, Rakic, et al. "Multiple Benefits of Empagliflozin in PCOS: Evidence from a Preclinical Rat Model." Pathophysiology : The Official Journal of the International Society for Pathophysiology, vol. 31, no. 4, 2024, p. 559, https://doi.org/10.3390/pathophysiology31040041.